50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
NASDAQ:ZEAL

Zealand Pharma A/S - ZEAL News Today

$17.59
+0.21 (+1.21%)
(As of 09/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$17.47
$18.07
50-Day Range
$16.20
$20.25
52-Week Range
$9.93
$32.94
Volume
2,156 shs
Average Volume
4,966 shs
Market Capitalization
$818.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Zealand Pharma A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter.



ZEAL Media Mentions By Week

ZEAL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZEAL
News Sentiment

1.00

0.80

Average
Medical
News Sentiment

ZEAL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZEAL Articles
This Week

1

1

ZEAL Articles
Average Week

SourceHeadline
msn.com logoNew Zealand sees greatest jump in adult wealth in world
msn.com - September 22 at 5:04 AM
finance.yahoo.com logoZealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)
finance.yahoo.com - September 21 at 8:32 AM
MarketBeat logoZealand Pharma A/S (NASDAQ:ZEAL) Shares Gap Down to $18.15
americanbankingnews.com - September 21 at 6:54 AM
investing.com logoZealand Pharma A/S ADR (ZEAL)
investing.com - September 15 at 12:19 AM
finance.yahoo.com logoZealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
finance.yahoo.com - September 7 at 3:33 PM
finance.yahoo.com logoZealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
finance.yahoo.com - September 7 at 3:33 PM
seekingalpha.com logoZealand Pharma A/S (ZEAL) CEO Adam Steensberg on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 3:20 PM
finance.yahoo.com logoZealand Pharma Announces Financial Results for the First Half of 2022
finance.yahoo.com - August 11 at 9:37 AM
finance.yahoo.com logoZealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select Market
finance.yahoo.com - August 8 at 5:58 PM
finance.yahoo.com logoZealand Pharma AS (ZEAL) Stock Jumps 9.1%: Will It Continue to Soar?
finance.yahoo.com - July 21 at 1:17 PM
msn.com logoPristine Biologicals inaugurates New Sterile Filtered Serum manufacturing facility in New Zealand’s Dargaville
msn.com - July 11 at 6:58 PM
benzinga.com logoMediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
benzinga.com - July 11 at 6:58 PM
msn.com logoNew Zealand’s medicines budget to boost R&D-based drugmakers
msn.com - July 5 at 8:08 AM
finance.yahoo.com logoZealand Pharma to Participate in Upcoming Investor Conferences
finance.yahoo.com - June 3 at 8:56 AM
seekingalpha.com logoDr. David Kendall named Zealand Pharma CMO
seekingalpha.com - June 2 at 7:33 AM
finance.yahoo.com logoZealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer
finance.yahoo.com - June 2 at 2:33 AM
finance.yahoo.com logoZealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes Association Scientific Sessions, Including Initial Clinical Data on GLP-1/GLP-2 Dual Agonist Dapiglutide
finance.yahoo.com - May 31 at 10:21 AM
finance.yahoo.com logoZealand Pharma launches long-term incentive program for Zealand’s Corporate Management and employees for 2022
finance.yahoo.com - May 25 at 5:03 PM
investing.com logo"We Think There is a Good Chance of Broad-label Approval" - Needham & Company Bullish on Zealand Pharma Following Phase 3 Data
investing.com - May 19 at 3:28 PM
marketwatch.com logoZealand Pharma Shares Rise 16% After Trial Results for Dasiglucagon
marketwatch.com - May 19 at 3:28 PM
markets.businessinsider.com logoWhy Zealand Pharma Shares Are Rising
markets.businessinsider.com - May 19 at 3:28 PM
msn.com logoZealand Pharma's Dasiglucagon Aces Late-Stage Study In Pediatric Patients, Shares Move Higher
msn.com - May 19 at 10:03 AM
seekingalpha.com logoZealand Pharma stock soars 17% as dasiglucagon meets main goal in congenital hyperinsulinism study in infants
seekingalpha.com - May 19 at 10:03 AM
finance.yahoo.com logoZealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatric Patients with Congenital Hyperinsulinism (CHI)
finance.yahoo.com - May 19 at 10:03 AM
finance.yahoo.com logoZealand Pharma to seek FDA approval of its treatment for rare genetic disorder in babies
finance.yahoo.com - May 19 at 10:03 AM
seekingalpha.com logoMannKind to acquire insulin delivery device V-Go from Zealand Pharma to bolster diabetes portfolio
seekingalpha.com - May 17 at 12:06 PM
nasdaq.com logoMannKind Corp. To Acquire V-Go From Zealand Pharma - Quick Facts
nasdaq.com - May 17 at 12:06 PM
marketwatch.com logoMannKind Buys V-Go Insulin Device From Zealand Pharma For $10M, Milestones
marketwatch.com - May 17 at 6:32 AM
finance.yahoo.com logoMannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand Pharma
finance.yahoo.com - May 17 at 6:32 AM
finance.yahoo.com logoZealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device
finance.yahoo.com - May 17 at 6:32 AM
seekingalpha.com logoZealand Pharma A/S (ZEAL) CEO Adam Steensberg on Q1 2022 Earnings Call Transcript
seekingalpha.com - May 12 at 5:42 PM
finance.yahoo.com logoTransactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED]
finance.yahoo.com - May 12 at 5:42 PM
finance.yahoo.com logoZealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Development
finance.yahoo.com - May 12 at 12:42 PM
benzinga.com logoEarnings Outlook For Zealand Pharma
benzinga.com - May 11 at 11:39 AM
finance.yahoo.com logoZealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022
finance.yahoo.com - May 10 at 5:58 PM
seekingalpha.com logoZealand Pharma, Oberland Capital amend financing contract
seekingalpha.com - May 10 at 7:39 AM
markets.businessinsider.com logoNew Zealand Trade Shortfall NZ$392 Million In March
markets.businessinsider.com - April 27 at 10:59 PM
nasdaq.com logoApart from Stock Price, What’s Up with Tilray?
nasdaq.com - April 20 at 3:12 PM
finance.yahoo.com logoCorrection: Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 2022
finance.yahoo.com - April 7 at 1:30 PM
finance.yahoo.com logoZealand Pharma major shareholder announcement: The Capital Group Companies, April 7 2022
finance.yahoo.com - April 7 at 3:29 AM
finance.yahoo.com logoZealand Pharma's Annual General Meeting 2022
finance.yahoo.com - April 6 at 12:27 PM
apnews.com logoZealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference
apnews.com - April 4 at 3:22 PM
finance.yahoo.com logoZealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 4 at 3:22 PM
seekingalpha.com logoSonoma Pharma rises 22% on UTI product launch in New Zealand, Australia and South Africa
seekingalpha.com - March 30 at 12:04 PM
seekingalpha.com logoZealand Pharma stock rises 10% on restructuring plan, new CEO
seekingalpha.com - March 30 at 12:04 PM
marketwatch.com logoZealand Pharma to Restructure, Names Adam Steensberg New CEO
marketwatch.com - March 30 at 12:04 PM
finance.yahoo.com logoZealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations
finance.yahoo.com - March 30 at 12:04 PM
seekingalpha.com logoZealand Pharma reports FY results
seekingalpha.com - March 11 at 2:04 PM
finance.yahoo.com logoCorrection: Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.
finance.yahoo.com - March 11 at 2:04 PM
finance.yahoo.com logoZealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.
finance.yahoo.com - March 10 at 12:51 PM
Get Zealand Pharma A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ZEAL) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.